Clinical Trials Logo

Glucose clinical trials

View clinical trials related to Glucose.

Filter by:

NCT ID: NCT05958368 Recruiting - Clinical trials for Diabetes Mellitus, Type 2

Assessing the Value of Avocados on Glycemic Control in Type 2 Diabetes

AVOCADO-T2D
Start date: October 10, 2023
Phase: N/A
Study type: Interventional

The objective of this study is to assess the effects of Hass Avocados on glycemic control. The investigators hypothesize that Hass Avocado consumption will reduce fasting blood sugar compared to an isocaloric amount of other fruit during controlled feeding.

NCT ID: NCT05353322 Recruiting - Blood Pressure Clinical Trials

Breaking up Prolonged Sedentary Behavior to Improve Cardiometabolic Health

Start date: June 30, 2022
Phase: N/A
Study type: Interventional

The purpose of this Phase 1 research study is to answer two questions: (1) How frequent should periods of prolonged sedentary time be interrupted? and (2) What is the appropriate duration or length of time of these breaks in sedentary time? To address these questions, this project will conduct a state-of-the-art adaptive dose finding study under controlled laboratory conditions to determine the minimally effective dose (the smallest dose) that yields cardiometabolic benefit for two separate sedentary break elements (frequency and duration). Study findings will ultimately determine how often and for how long people should break up periods of prolonged sedentary time to transiently improve established cardiovascular risk factors; key foundational information critical to the success of future long-term trials and ultimately public health guidelines. Primary Aim: To determine the minimally effective dose combination(s) of frequency and duration needed to provide cardiometabolic benefit during an 8-hour experimentation period. Specifically, the study will determine: 1a. For each fixed duration, the minimum sedentary break frequency (e.g., every 30 min, 60 min, 120 min) that demonstrates a reduction in systolic BP, diastolic BP, or glucose compared with a sedentary control condition. 1b. For each fixed frequency, the minimum sedentary break duration (e.g., activity breaks of 1 min, 5 min, 10 min) that demonstrates a reduction in systolic BP, diastolic BP, or glucose compared with a sedentary control. Secondary Aim: It is also critical to public health strategy to assess the acceptability/feasibility of various sedentary break doses as too high a dose will yield poor uptake. To address this need, the maximally tolerated dose (the highest dose that does not cause undue physical/psychological distress) for frequency and duration of sedentary breaks will also be determined via assessment of 4 constructs: physical exhaustion/fatigue, affect (e.g., mood, emotion), tolerability (e.g., completion of dose protocol), and safety (e.g., hypoglycemia). Maximally tolerated dose will be defined as the highest dose where <20% of participants exhibit an adverse outcome.

NCT ID: NCT04782934 Completed - Diabetes Mellitus Clinical Trials

The GLOW Study - The YANG System

Start date: February 25, 2021
Phase: N/A
Study type: Interventional

This is an open label, interventional, monocentric, prospective early feasibility study, designed to evaluate the safety of implant and short-term integration into the tissue of the YANG sensor. In addition, the set up will enable data collection which will be used to develop the software algorithm to allow real-time, continuous measurement of glucose, ketone and lactate levels in the interstitial fluid in adults with diabetes mellitus, in a future version of the device.

NCT ID: NCT04562714 Completed - Clinical trials for Diabetes Mellitus, Type 2

Impact of Flash Glucose Monitoring in People With Type 2 Diabetes Using Non-Insulin Antihyperglycemic Therapy

IMMEDIATE
Start date: September 8, 2020
Phase: N/A
Study type: Interventional

The objective of this study is to evaluate the effectiveness of a flash glucose monitor device in achieving optimal glycemic control among adults with type 2 diabetes inadequately controlled with non-insulin antihyperglycemic therapy.

NCT ID: NCT04532801 Recruiting - Healthy Volunteers Clinical Trials

Evaluation of Kisspeptin Glucose-Stimulated Insulin Secretion With Physiologic Mixed Meal Tolerance

Start date: September 1, 2019
Phase: Phase 1
Study type: Interventional

This study utilizes infusions of kisspeptin in healthy women to isolate the impact of kisspeptin on beta-cell responsivity assessed by the mixed meal tolerance test.

NCT ID: NCT04051294 Completed - Clinical trials for Glucose Metabolism Disorders (Including Diabetes Mellitus)

The Effect of Kombucha on Blood Sugar Levels in Humans

Start date: January 3, 2019
Phase: N/A
Study type: Interventional

As a phase 0 clinical trial, we will learn how kombucha influences glucose metabolism in humans.

NCT ID: NCT03464084 Completed - Circadian Rhythm Clinical Trials

Interaction of Melatonin With MTNR1B Genotype on Glucose Control - Study 2

Start date: February 17, 2018
Phase: N/A
Study type: Interventional

This project aims to test the impact of melatonin and MTNR1B variation on regulation glucose regulation in a highly controlled in-laboratory setting and ex vivo in pancreatic islets.

NCT ID: NCT03233906 Active, not recruiting - Obesity Clinical Trials

The Effects of Chia on Overweight/Obese Women

Start date: May 20, 2017
Phase: N/A
Study type: Interventional

The purpose of the study is to examine the effect of chia seed consumption on body composition, blood pressure, blood glucose, satiety, mood, joint pain, and dietary displacement in overweight and obese females (18-45years). It is hypothesized that consuming chia seeds will bring about a positive change in body composition (lower % body fat), satiety, mood, joint pain, and blood pressure, lower blood glucose levels, increased fiber and improved nutrient intake, in overweight/ obese females.

NCT ID: NCT02642640 Completed - Circadian Rhythm Clinical Trials

Interaction of Melatonin and MTNR1B Genotype on Glucose Control - Study 1

Start date: November 2016
Phase: N/A
Study type: Interventional

This project aims to test the impact of melatonin and MTNR1B variation on regulation glucose regulation in a highly controlled in-laboratory setting and ex vivo in pancreatic islets.

NCT ID: NCT01398059 Completed - Feasibility Clinical Trials

The Metabolic Effects of Breaks in Sedentary Time

Start date: July 2011
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether acute bouts of sedentary behaviour (with or without breaks and/or structured physical activity) result in measurable changes in metabolic health in children and youth.